Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Am J Nephrol. 2019 Dec 10;51(1):43–53. doi: 10.1159/000504869

Table 2:

Information on genetic diagnosis in 75 individuals who underwent next generation sequencing and histological diagnosis by renal pathological diagnostic group.

Pathological Diagnosis Genetic Diagnosis Number affected

Tubulointerstitial Kidney Disease (n=18) MUC1 6 (34%)
UMOD 4 (22%)
HNF1B 1 (5.5%)
NPHP 1 1 (5.5%)
IFT140 1 (5.5%)
No diagnosis 5 (27.5%)

Chronic Glomerulonephritis (n = 15) COL4A5 2 (13%)
UMOD 1 (7%)
MUC1 1 (7%)
No Diagnosis 11 (73%)

Focal Segmental Glomerulosclerosis/Alport Syndrome (n=11) COL4A5 5 (45%)
FANCI 1 (10%)
No Diagnosis 5(45%)

Thrombotic Microangiopathy (n=17) UMOD 2 (11.5%)
HNF1B 2 (11.5%)
MUC1 1 (6%)
INF2 4 (24%)
IFT140 1 (6%)
No Diagnosis 7 (41%)

Non-specific causes (n=14) COL4A5 1 (7%)
C3 1 (7%)
WNK4 1 (7%)
SLC3A1 1 (7%)
HNF1B 1 (7%)
INF2 1 (7%)
No Diagnosis 8 (58%)